Rosebud Biosciences Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$275K
- Investors
-
9
Rosebud Biosciences General Information
Description
Developer of a drug discovery platform designed to provide therapies for rare genetic diseases in children. The company's platform specializes in modelling human development with organoids that have the same gene mutation as the child and screens drugs in these models to find cures using machine learning and the latest molecular advances, enabling doctors to minimize the cost and time for pre-clinical testing of novel and repurposed drugs.
Contact Information
Website
www.rosebudbiosci.comCorporate Office
- 63 Via Floreado
- Orinda, CA 94563-1924
- United States
Corporate Office
- 63 Via Floreado
- Orinda, CA 94563-1924
- United States
Rosebud Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 15-Aug-2023 | $275K | Completed | Product Development | ||
| 3. Early Stage VC | 14-Apr-2022 | Completed | Product Development | |||
| 2. Accelerator/Incubator | 29-Mar-2022 | $500K | $500K | Completed | Product Development | |
| 1. Early Stage VC (Series 1) | 27-Mar-2022 | Completed | Product Development |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Rosebud Biosciences Patents
Rosebud Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4463552-A2 | Bancr compositions and methods for treating disease | Pending | 14-Jan-2022 | ||
| EP-4463552-A4 | Bancr compositions and methods for treating disease | Pending | 14-Jan-2022 | ||
| US-20250092394-A1 | Bancr compositions and methods for treating disease | Pending | 14-Jan-2022 | ||
| WO-2023137260-A2 | Bancr compositions and methods for treating disease | Inactive | 14-Jan-2022 | ||
| WO-2023137260-A3 | Bancr compositions and methods for treating disease | Inactive | 14-Jan-2022 | C12N15/113 |
Rosebud Biosciences Signals
Rosebud Biosciences Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| US National Science Foundation | Accelerator/Incubator | |||
| 10X Capital | Venture Capital | Minority | ||
| Arvantis Group | Holding Company | Minority | ||
| Gaingels | Venture Capital | Minority | ||
| Y Combinator | Accelerator/Incubator | Minority |
Rosebud Biosciences FAQs
-
When was Rosebud Biosciences founded?
Rosebud Biosciences was founded in 2020.
-
Where is Rosebud Biosciences headquartered?
Rosebud Biosciences is headquartered in Orinda, CA.
-
What is the size of Rosebud Biosciences?
Rosebud Biosciences has 4 total employees.
-
What industry is Rosebud Biosciences in?
Rosebud Biosciences’s primary industry is Drug Discovery.
-
Is Rosebud Biosciences a private or public company?
Rosebud Biosciences is a Private company.
-
What is Rosebud Biosciences’s current revenue?
The current revenue for Rosebud Biosciences is .
-
How much funding has Rosebud Biosciences raised over time?
Rosebud Biosciences has raised $500K.
-
Who are Rosebud Biosciences’s investors?
US National Science Foundation, 10X Capital, Arvantis Group, Gaingels, and Y Combinator are 5 of 9 investors who have invested in Rosebud Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process